# Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

> **NCT06795373** · PHASE2 · WITHDRAWN · sponsor: **Ahuva D Cices**

## Conditions studied

- Chronic Spontaneous Urticaria
- CSU

## Interventions

- **DRUG:** Ritlecitinib

## Key facts

- **NCT ID:** NCT06795373
- **Lead sponsor:** Ahuva D Cices
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12-31
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor terminated study
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795373, "Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06795373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*